‘Radical’ bill seeks to reduce cost of AIDS drugs by awarding prizes instead of patents

Abstract

A radical proposal suggests substituting the current patent system with a prize system for the development of anti-AIDS drugs. The aim is to lower drug costs by offering pharmaceutical companies a share of a prize pool rather than exclusive rights to newly developed drugs. Proponents argue that this system would encourage competition and result in lower prices and more rapid innovation. Conversely, opponents contend that it would discourage investment in drug development and hinder the development of follow-on drugs. – AI-generated abstract.